Journal article
Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors
Markus Juonala, Costan G Magnussen, Gerald S Berenson, Alison Venn, Trudy L Burns, Matthew A Sabin, Sathanur R Srinivasan, Stephen R Daniels, Patricia H Davis, Wei Chen, Cong Sun, Michael Cheung, Jorma SA Viikari, Terence Dwyer, Olli T Raitakari
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2011
Grants
Awarded by Academy of Finland
Awarded by National Health and Medical Research Council
Awarded by National Institute on Aging
Awarded by National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH)
Awarded by National Heart, Lung, and Blood Institute
Awarded by NIH
Funding Acknowledgements
These analyses were supported by funding from the individual studies. The Cardiovascular Risk in Young Finns Study was supported by grants from the Academy of Finland (121584, 126925, 124282, 129378), the Social Insurance Institution of Finland, the Turku University Foundation, Special Federal Grants for University Hospitals, the Juho Vainio Foundation, Paavo Nurmi Foundation, the Finnish Foundation of Cardiovascular Research, Orion-Farmos Research Foundation, and the Finnish Cultural Foundation. The Childhood Determinants of Adult Health study was supported at baseline by the Commonwealth Departments of Sport, Recreation and Tourism, and Health; the National Heart Foundation; and the Commonwealth Schools Commission and at follow-up by the National Health and Medical Research Council, the Heart Foundation, the Tasmanian Community Fund, and Veolia Environmental Services; authors from the Murdoch Children's Research Institute are supported by the Victorian Government Operational Infrastructure Support Program; Dr. Sabin is supported through a National Health and Medical Research Council Health Professional Training Fellowship (APP1012201). The Bogalusa Heart Study was supported by grants from the National Institute on Aging (AG-16592) and the National Heart, Lung, and Blood Institute (HL-38844) of the National Institutes of Health (NIH) and from the American Heart Association. The Muscatine Study was supported by grants from the National Heart, Lung, and Blood Institute (HL-14230 and HL-54730), and the General Clinical Research Centers Program (RR-00059) of the NIH.Dr. Sabin reports receiving lecture fees from Pfizer; Dr. Daniels, receiving consulting fees from Merck; and Dr. Viikari, receiving lecture fees from Merck, AstraZeneca, and Pfizer. No other potential conflict of interest relevant to this article was reported.